Acne: The Evidence-Based Supplement Protocol

6 min read ·

The most effective acne interventions remain topical retinoids, benzoyl peroxide, and (where indicated) oral isotretinoin or hormonal therapy. But four supplements have credible RCT evidence for moderate inflammatory acne, particularly as adjuncts in adults who cannot tolerate oral antibiotics or who have completed an isotretinoin course and need a maintenance approach.

Oral Zinc, 30 mg Elemental Daily

Zinc is the supplement with the strongest acne evidence. A 2020 meta-analysis of 23 RCTs concluded that oral zinc reduced inflammatory acne lesion counts versus placebo, with effect sizes smaller than tetracyclines but with markedly better long-term safety. The mechanism involves direct anti-inflammatory action on neutrophils, 5-alpha-reductase inhibition in sebocytes, and reduced Cutibacterium acnes growth. Use 30 mg of elemental zinc as gluconate or picolinate; do not exceed 40 mg daily without supplementing 1–2 mg copper. See our zinc form piece.

Oral Nicotinamide (Niacinamide) 500 mg Twice Daily

Nicotinamide is the amide form of vitamin B3 (distinct from niacin). Oral nicotinamide 500–1,000 mg daily has reduced inflammatory lesion counts in multiple controlled trials, and is well-tolerated with no flushing (unlike niacin). The mechanism includes downregulation of IL-1β and IL-8 in inflamed sebaceous units. It is a reasonable choice for adults who cannot use oral doxycycline. See our niacinamide piece.

EPA-Dominant Omega-3, 2 g EPA + DHA Daily

A 2014 RCT in 60 adults with moderate inflammatory acne tested omega-3 supplementation versus placebo over 10 weeks and found significant reductions in inflammatory lesion counts and leukotriene B4 levels. The mechanism likely involves resolution of the chronic inflammatory tone in sebaceous units. See our skin health stack.

Vitamin D to Repletion (Serum 25-OH-D 30–50 ng/mL)

Multiple cross-sectional studies have shown lower mean serum vitamin D in adults with acne versus controls, and a 2016 Korean RCT showed that supplementing to repletion reduced inflammatory lesion counts versus placebo. The effect is strongest in adults starting frankly deficient. Don't dose blindly — test 25-OH-D and supplement to target. See our vitamin D acne piece.

What NOT to Take

Avoid high-dose biotin — it has no acne evidence and interferes with thyroid lab assays. Skip "skin clearing" megadose vitamin A products — vitamin A toxicity is real and serious, and topical retinoids are far safer and more effective. Avoid pantothenic acid (B5) high-dose protocols — the small positive trials have not been replicated and the doses (10,000+ mg) carry GI and theoretical safety risks. For diet-driven acne, low-glycemic-index changes and reduced dairy have better evidence than any supplement. See the broader skin inflammation context and our vitamin D guide.

How to Run the Protocol

Topical retinoid + benzoyl peroxide remain first-line; this protocol sits underneath them. Get baseline 25-OH-D. Start zinc 30 mg elemental + omega-3 2 g daily + vitamin D to repletion. Add nicotinamide 500 mg twice daily if the first three plus topicals are inadequate at 12 weeks. Re-evaluate inflammatory lesion count at week 16. Maintenance protocols can include zinc + omega-3 long-term.

Sources

  1. Yee BE, Richards P, Sui JY, Marsch AF. "Serum zinc levels and efficacy of zinc treatment in acne vulgaris: a systematic review and meta-analysis." Dermatologic Therapy, 2020;33(6):e14252. PMID: 32860489. DOI: 10.1111/dth.14252.
  2. Walocko FM, Eber AE, Kerdel FA, et al. "The role of nicotinamide in acne treatment." Dermatologic Therapy, 2017;30(5):e12481. PMID: 28220628. DOI: 10.1111/dth.12481.
  3. Khayef G, Young J, Burns-Whitmore B, Spalding T. "Effects of fish oil supplementation on inflammatory acne." Lipids in Health and Disease, 2012;11:165. PMID: 23206895. DOI: 10.1186/1476-511X-11-165.
  4. Lim SK, Ha JM, Lee YH, et al. "Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial." PLoS One, 2016;11(8):e0161162. PMID: 27560161. DOI: 10.1371/journal.pone.0161162.
  5. Zaenglein AL, Pathy AL, Schlosser BJ, et al. "Guidelines of care for the management of acne vulgaris." JAAD, 2016;74(5):945-973. PMID: 26897386. DOI: 10.1016/j.jaad.2015.12.037.